deferoxamine has been researched along with Spinal Diseases in 4 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Spinal Diseases: Diseases involving the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A new constellation of spinal changes are observed in homozygous beta-thalassemia major (HBT) patients receiving deferoxamine (DF), an iron-chelating drug used in combination with transfusion therapy in certain anemic syndromes." | 7.68 | Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients. ( Babyn, PS; Hartkamp, MJ; Olivieri, F, 1993) |
| "A new constellation of spinal changes are observed in homozygous beta-thalassemia major (HBT) patients receiving deferoxamine (DF), an iron-chelating drug used in combination with transfusion therapy in certain anemic syndromes." | 3.68 | Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients. ( Babyn, PS; Hartkamp, MJ; Olivieri, F, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orzincolo, C | 1 |
| Castaldi, G | 1 |
| Scutellari, PN | 1 |
| Hartkamp, MJ | 1 |
| Babyn, PS | 1 |
| Olivieri, F | 1 |
| Levin, TL | 1 |
| Sheth, S | 1 |
| Berdon, WE | 1 |
| Ruzal-Shapiro, C | 1 |
| Piomelli, S | 1 |
| Naselli, A | 1 |
| Vignolo, M | 1 |
| Di Battista, E | 1 |
| Garzia, P | 1 |
| Forni, GL | 1 |
| Traverso, T | 1 |
| Aicardi, G | 1 |
4 other studies available for deferoxamine and Spinal Diseases
| Article | Year |
|---|---|
Platyspondyly in treated beta-thalassemia.
Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Body Height; Child; Combined Modality Therapy; Defe | 1994 |
Spinal deformities in deferoxamine-treated homozygous beta-thalassemia major patients.
Topics: Adolescent; beta-Thalassemia; Calcinosis; Child; Child, Preschool; Deferoxamine; Dose-Response Relat | 1993 |
Deferoxamine-induced platyspondyly in hypertransfused thalassemic patients.
Topics: Adult; beta-Thalassemia; Body Height; Deferoxamine; Female; Follow-Up Studies; Hemosiderosis; Humans | 1995 |
Long-term follow-up of skeletal dysplasia in thalassaemia major.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Body Height; Bone Diseases, Developmental; D | 1998 |